Ramasamy Jagadeeswaran to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Ramasamy Jagadeeswaran has written about Xenograft Model Antitumor Assays.
Connection Strength
0.036
-
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res. 2009 Apr 01; 69(7):3021-31.
Score: 0.019
-
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts. Cancer Res. 2007 Apr 15; 67(8):3529-34.
Score: 0.017